SCHEMBL8768913

SCHEMBL8768913

NC(=O)CCC(NCO)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
ALOX15 P16050 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48
MMP2 P08253 2/20 0.43
MMP9 P14780 2/20 0.43
CA2 P00918 5/20 0.42
CA1 P00915 4/20 0.42
FOLH1 Q04609 4/20 0.41
RIMKLA Q8IXN7 1/20 0.41
NAALAD2 Q9Y3Q0 1/20 0.41
TGFBR1 P36897 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GGT1 P19440 1/20 0.38
GGH Q92820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768917 1.00 KMT2A (0.48) KMT2AALOX15BLMPMP22MMP2
SCHEMBL6554061 0.86 KMT2A (0.47) KMT2AALOX15BLMPMP22MMP2
SCHEMBL21802287 0.86 KMT2A (0.47) KMT2AALOX15BLMPMP22MMP2
SCHEMBL28142279 0.84 KMT2A (0.45) KMT2AALOX15BLMPMP22MMP2
SCHEMBL2177303 0.84 KMT2A (0.45) KMT2AALOX15BLMPMP22MMP2
SCHEMBL1226472 0.84 KMT2A (0.45) KMT2AALOX15BLMPMP22MMP2
SCHEMBL22042 0.84 KMT2A (0.45) KMT2AALOX15BLMPMP22MMP2
SCHEMBL6156358 0.84 KMT2A (0.45) KMT2AALOX15BLMPMP22MMP2
SCHEMBL6031102 0.83 KMT2A (0.41) KMT2AALOX15BLMPMP22MMP2
SCHEMBL149082 0.83 KMT2A (0.48) KMT2AALOX15BLMPMP22MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0213996-B1 RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1989-09-06 EP claimed
EP-0792146-A1 INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES HEMASURE, INC. (US) 1997-09-03 EP disclosed
WO-1997002028-A1 INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES HEMASURE, INC. (US) 1997-01-23 WO disclosed